Portal Vein Thrombosis Clinical Trials

70 clinical trials for Portal Vein Thrombosis across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Progression of cavernous transformed non-cirrhotic portal vein thrombosis (KAVERNOM study) — RECRUITING
• Freiburg TIPS Registry — RECRUITING
• Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis — RECRUITING · PHASE4
• Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD — RECRUITING · NA
• Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS — RECRUITING · NA
• Indicators Affecting PVT Recanalization — RECRUITING
• A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation — RECRUITING
• Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC — RECRUITING · PHASE4
• LMU-PVT_Safety, technical and clinical success rate of interventional portal vein recanalization — RECRUITING
• Assessment of arterial flow characteristics in thrombotic and haemostatic plug formation using CT and DSA — RECRUITING
• Controlled Anticoagulation After Portal Vein Reconstruction with Pancreatic Resection (CAPTAIN‐Trial) — NOT_YET_RECRUITING
• Indirect trans-arterial thrombolysis versus Anticoagulation alone for therapy of portal and/or splanchnic thromboses - a retrospective controlled trial — OTHER
• Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis — NOT_YET_RECRUITING · NA
• Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis — COMPLETED · PHASE4
• Portal Vein Thrombosis in Liver Cirrhosis: Clinical Characteristics, Radiological Patterns, and Predictors — ACTIVE_NOT_RECRUITING
• Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion — COMPLETED · PHASE2
• Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation — NOT_YET_RECRUITING
• HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT — COMPLETED · PHASE2
• Portal Vein Stenting for Malignant Obstruction: Feasibility, Safety, and Clinical Outcomes — COMPLETED
• Endoscopic Ultrasound-guided Measurement of Portal Vein Pressure Gradient — NOT_YET_RECRUITING · NA
• The Impact of Nonselective Beta-Blocker Therapy on Portal Vein Thrombosis Risk After Liver Resection in Cirrhotic Patients — OTHER
• Chances in Portal System Flow After Two Bariatric Procedures — WITHDRAWN · NA
• Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. — COMPLETED
• Prevalence of JAK-2 mutations in patients with abdominal venous thromboses — OTHER
• Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis — NOT_YET_RECRUITING · PHASE2
• Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis — COMPLETED · PHASE2
• Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT — OTHER · NA
• Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome — OTHER
• Vienna Vascular Liver Disease Study — OTHER
• Portal Vein Thrombosis in Neonate With Umbilical Catheter — OTHER
• Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery — TERMINATED
• Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis — NOT_YET_RECRUITING · NA
• Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in Children — OTHER
• Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring — COMPLETED
• H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis — OTHER · PHASE2
• Register non-cirrhotic portal vein thrombosis — OTHER
• SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT — OTHER · PHASE3
• Comparison of color doppler ultrasound, computer tomography and angiography in the diagnosis of acute portal vein thrombosis — OTHER
• TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis — OTHER · NA
• Safety of Anticoagulant Therapy After Endoscopic Treatment — COMPLETED · PHASE4
• A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis — COMPLETED
• IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation — OTHER · NA
• Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis — WITHDRAWN · PHASE1
• Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis — COMPLETED
• Influence of Metabolic Profiles on Drug Safety in Routine Care — OTHER
• Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis — OTHER · NA
• Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients — COMPLETED
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis — COMPLETED · PHASE4
• Neo-TACE-HAIC for PVTT-HCC — OTHER · NA
• EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications — COMPLETED · NA

Refine this search